STOCKNO.DE
Institutional ownership intelligence
Research
Schedule 13G/A

TXG Schedule 13G/A filing by Fidelity / FMR

Fidelity / FMR reported beneficial ownership of 18.5M shares, representing 15.6% of 10x Genomics, Inc. in this filing.

FiledMar 6, 2026
Ownership dateFeb 27, 2026
Reported shares18.5M
Reported ownership15.6%
Ownership details

Voting and dispositive power reported in the filing

These figures describe the reporting filer’s disclosed voting and investment authority. They should be read together with the reported share count and percentage.

Sole voting power 18.5M
Shared voting power 18.5K
Sole dispositive power 18.5K
Shared dispositive power 18.5K
Price context

Price dates alongside the ownership filing

Price data provides market context around the disclosure. It does not identify the filer’s actual transaction price.

Close near filing date$20.81as of Mar 6, 2026
Latest tracked price$47.46as of Aug 5, 2026
Source

Original filing and accession

Use the SEC filing as the primary source when you need the complete disclosure, footnotes, exhibits, or reporting-person details.

Reporting filer
Fidelity / FMR
CIK
CIK0000315066
Accession
0000315066-26-000666
Form
Schedule 13G/A
Open SEC filing View TXG ownership history
Read the filing in context

Understand what a Schedule 13 filing does—and does not—tell you.

How to read a Schedule 13G → Does a 13G mean the shares were just bought? → Filing date vs. ownership date →